C83.65 Undifferentiated (diffuse) non-Hodgkin's lymphoma, lymph nodes of inguinal region and lower limb

Name of the Condition

• Undifferentiated (diffuse) non-Hodgkin's lymphoma, lymph nodes of inguinal region and lower limb
• Also known as ICD-10 code C83.65

Summary

Undifferentiated (diffuse) non-Hodgkin's lymphoma is a subtype of non-Hodgkin lymphoma characterized by the malignant proliferation of lymphoid cells that lack distinct differentiation or follicular structure. It typically involves abnormal growth of B-cells or T-cells in lymph nodes or other lymphoid tissues, with a diffuse pattern of spread. This condition specifically affects the lymph nodes of the inguinal region and lower limb and is part of the broader category of non-follicular lymphomas.

Causes

The exact cause of undifferentiated (diffuse) non-Hodgkin's lymphoma remains unknown. It is thought to involve genetic mutations or abnormalities in lymphoid cell development, though specific triggers are not well-defined. Research suggests potential links to immune system dysregulation or prior infections, but no definitive etiology has been established.

Risk Factors

• Age: More common in older adults.
• Family history of lymphoma.
• Prior exposure to radiation or certain chemicals.
• Chronic infections, such as hepatitis C or HIV.
• Immunosuppressive conditions or treatments.

Symptoms

• Swollen, painless lymph nodes in the inguinal region or lower limb.
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.
• Loss of appetite.

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI) to assess lymph node involvement, and biopsy of the affected lymph node to confirm the presence of malignant lymphoid cells. Additional tests, such as blood work or bone marrow biopsy, may be performed to evaluate disease extent and subtype. Pathological analysis is essential to distinguish this condition from other lymphomas or malignancies.

Treatment Options

Treatment depends on the stage, subtype, and patient factors and may include chemotherapy, immunotherapy, radiation therapy, or targeted therapies. Multimodal approaches are common, and treatment plans are tailored to individual cases. Clinical trials may be an option for some patients.

Prognosis and Follow-Up

Prognosis varies based on the subtype, stage at diagnosis, and response to treatment. Regular follow-up with imaging and clinical assessments is important to monitor for recurrence or progression. Long-term surveillance is typically recommended.

Complications

Potential complications include disease progression, treatment-related side effects (e.g., infection risk from immunosuppression), organ dysfunction due to lymph node compression, or transformation to a more aggressive subtype.

Lifestyle & Prevention

While prevention is not fully established, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., excessive radiation exposure) may support overall health. Early detection through prompt evaluation of persistent symptoms is key.

When to Seek Professional Help

Seek medical attention for persistent swollen lymph nodes, unexplained weight loss, fever, night sweats, or fatigue, especially if symptoms worsen or do not resolve. Prompt evaluation is important for timely diagnosis and management.

Tips for Medical Coders

Use code C83.65 for undifferentiated (diffuse) non-Hodgkin's lymphoma specifically involving the lymph nodes of the inguinal region and lower limb. Ensure documentation supports the anatomical site and confirms the diagnosis. Verify that the code aligns with the clinical findings and avoid using this code for other lymphoma subtypes or sites.